Scaling up antiretroviral therapy for HIV-infected children in côte d'ivoire: Determinants of survival and loss to programme

Bulletin of the World Health Organization

Volumn 88, Issue 7, 2010, Pages 490-500

  Anaky, M F ^a   Duvignac, J ^b   Wemin, L ^a   Kouakoussui, A ^a   Karcher, S ^b   Toure S ^a   Seyler, C ^c   Fassinou, P ^d   Dabis, F ^b   N'Dri Yoman, T ^a   Anglaret, X ^b   Leroy, V ^b  

^a ACONDA VS CI   (Côte d’Ivoire)

^b INSERM   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; CHILD; CLINICAL TRIAL; COTE D'IVOIRE; EPIDEMIOLOGY; FEMALE; HIV INFECTIONS; HUMAN; INFANT; MALE; MORTALITY; MULTICENTER STUDY; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PATIENT DROPOUTS; PREGNANCY; PRESCHOOL CHILD; SERODIAGNOSIS; SOCIAL SUPPORT; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; AIDS SERODIAGNOSIS; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; COTE D'IVOIRE; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; PATIENT CARE MANAGEMENT; PATIENT DROPOUTS; PREGNANCY; SOCIAL SUPPORT;

EID: 77954471995     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.09.068015     Document Type: Article

References (45)

1. United Nations Programme for HIV/AIDS. 2008 report on the global AIDS epidemic. Geneva: UNAIDS; 2008.
2. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F; Ghent International AIDS Society (IAS) Working Group on HIV Infection in Women and Children. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004; 364: 1236-43. doi:10.1016/S0140-6736(04)17140-7 PMID:15464184
3. WHO HIV prevention and treatment guidelines. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings, towards universal access: recommendations for a public health approach (2006 version). Geneva: World Health Organization; 2006.
4. Coutsoudis A, Dabis F, Fawzi W, Gaillard P, Haverkamp G, Harris DR et al.; Breastfeeding and HIV International Transmission Study Group. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis 2004; 189: 2154-66. doi:10.1086/420834 PMID:15181561
5. Tonwe-Gold B, Ekouevi DK, Bosse CA, Toure S, Koné M, Becquet R et al. Implementing family-focused HIV care and treatment: the first 2 years' experience of the mother-to-child transmission-plus program in Abidjan, Cote d'Ivoire. Trop Med Int Health 2009; 14: 204-12. doi:10.1111/j.1365-3156.2008.02182.x PMID:19236666
6. De Baets AJ, Bulterys M, Abrams EJ, Kankassa C, Pazvakavambwa IE. Care and treatment of HIV-infected children in Africa: issues and challenges at the district hospital level. Pediatr Infect Dis J 2007; 26: 163-73. doi:10.1097/01. inf.0000253040.82669.22 PMID:17259881
7. Orne-Gliemann J, Becquet R, Ekouevi DK, Leroy V, Perez F, Dabis F. Children and HIV/AIDS: from research to policy and action in resource-limited settings. AIDS 2008; 22: 797-805. doi:10.1097/QAD.0b013e3282f4f45a PMID:18427197
8. Towards universal access. Scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009. Geneva: World Health Organization, United Nations Programme for HIV/AIDS, United Nations Children's Fund; 2009. Available from: http://www.who.int/hiv/pub/tuapr_2009_en.pdf [accessed 10 December 2009].
9. Fassinou P, Elenga N, Rouet F, Laguide R, Kouakoussui KA, Timite M et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire. AIDS 2004; 18: 1905-13. doi:10.1097/00002030-200409240-00006 PMID:15353976
10. Puthanakit T, Oberdorfer A, Akarathum N, Kanjanavanit S, Wannarit P, Sirisanthana T et al. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program. Clin Infect Dis 2005; 41: 100-107. doi:10.1086/430714 PMID:15937769
11. Chiappini E, Galli L, Tovo PA, Gabiano C, Gattinara GC, Guarino A et al.; Italian Register for HIV Infection in Children. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. AIDS 2006; 20: 207-215. doi:10.1097/01. aids.0000200529.64113.3e PMID:16511413
12. O'Brien DP, Sauvageot D, Zachariah R, Humblet P; Medecins Sans Frontieres. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. AIDS 2006; 20: 1955-60. doi:10.1097/01.aids.0000247117.66585.ce PMID:16988517
13. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi BH et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA 2007; 298: 1888-99. doi:10.1001/jama.298.16.1888 PMID:17954540
14. Sutcliffe CG, van Dijk JH, Bolton C, Persaud D, Moss WJ. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis 2008; 8: 477-489. doi:10.1016/S1473-3099(08)70180-4 PMID:18652994
15. Rabkin M, El-Sadr W, De Cock K; the Bellagio HIV/Health Systems Working Group. The impact of scale-up on health systems: a priority research agenda. JAcquirImmune Defic Syndr 2009; 52 (Suppl 1): S6-11. PMID:19858943
16. Anglaret X, Messou E, Ouassa T, Toure S, Dakoury-Dogbo N, Combe P et al.; ANRS 1203 Study Group. Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'Ivoire. AIDS 2003; 17: 575-584. doi:10.1097/00002030-200303070-00013 PMID:12598778
17. Toure S, Kouadio B, Seyler C, Traore M, Dakoury-Dogbo N, Duvignac J et al.; Aconda Study Group. Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants. AIDS 2008; 22: 873-882. doi:10.1097/QAD.0b013e3282f768f8 PMID:18427206
18. WHO HIV prevention and treatment guidelines. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants, towards universal access: recommendations for a public health approach. Geneva: World Health Organization; 2006.
19. Rouet F, Ekouevi DK, Inwoley A, Chaix ML, Burgard M, Bequet L et al. Field evaluation of a rapid human immunodeficiency virus (HIV) serial serologic testing algorithm for diagnosis and differentiation of HIV type 1 (HIV-1), HIV-2, and dual HIV-1-HIV-2 infections in West African pregnant women. J Clin Microbiol 2004; 42: 4147-4153. doi:10.1128/JCM.42.9.4147-4153.2004 PMID:15365003
20. Rouet F, Ekouevi DK, Chaix ML, Burgard M, Inwoley A, Tony TD et al. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. J Clin Microbiol 2005; 43: 2709-2717. doi:10.1128/JCM.43.6.2709-2717.2005 PMID:15956387
21. de Côte d'Ivoire R. Guide de prise en charge pédiatrique de l'infection par le VIH en Côte d'Ivoire. Abidjan: Ministère la Santé et de l'Hygiène Publique, Ministère de la Lutte contre le SIDA; 2006. French.
22. Harambat J, Fassinou P, Becquet R, Touré P, Rouet F, Dabis F et al.; ANRS 1201/1202 Ditrame Plus Study Group. 18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study. BMC Public Health 2008; 8: 169. doi:10.1186/1471-2458-8-169 PMID:18492259
23. WHO HIV prevention and treatment guidelines. Guidelines for co-trimoxazole prophylaxis for HIV-related infections in children, adults and adolescents in resource-limited settings: recommendations for a public health approach. Geneva: World Health Organization; 2006.
24. Zachariah R, Harries AD, Luo C, Bachman G, Graham SM. Scaling-up cotrimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries. Lancet Infect Dis 2007; 7: 686-93. doi:10.1016/ S1473-3099(07)70239-6 PMID:17897611
25. Rouet F, Fassinou P, Inwoley A, Anaky MF, Kouakoussui A, Rouzioux C et al.; ANRS 1244/1278 Programme Enfants Yopougon. Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens. AIDS 2006; 20: 2315-9. doi:10.1097/ QAD.0b013e328010943b PMID:17117017
26. Wamalwa DC, Farquhar C, Obimbo EM, Selig S, Mbori-Ngacha DA, Richardson BA et al. Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children. J Acquir Immune Defic Syndr 2007; 45: 311-7. PMID:17356470
27. Reddi A, Leeper SC, Grobler AC, Geddes R, France KH, Dorse GL et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr 2007; 7: 13. doi:10.1186/1471-2431-7-13 PMID:17367540
28. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA et al.; CHER Study Team. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008; 359: 2233-44. doi:10.1056/NEJMoa0800971 PMID:19020325
29. Newell ML, Patel D, Goetghebuer T, Thorne C; European Collaborative Study. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation? J Infect Dis 2006; 193: 954-62. doi:10.1086/500842 PMID:16518757
30. Faye A, Le Chenadec J, Dollfus C, Thuret I, Douard D, Firtion G et al.; French Perinatal Study Group. Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1. Clin Infect Dis 2004; 39: 1692-8. doi:10.1086/425739 PMID:15578372
31. KIDS-ART-LINC Collaboration. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. J Acquir Immune Defic Syndr 2008; 49: 523-31. doi:10.1097/QAI.0b013e31818aadce PMID:18989227
32. Smith K, Kuhn L, Coovadia A, Meyers T, Marais BJ, Barry G, et al. Immune reconstitution inflammatory syndrome in HIV-infected infants and young children initiating ART (abstract 75). In: Fifteenth Conference on Retroviruses and Opportunistic Infections, Boston, 3-6 February 2008.
33. Puthanakit T, Oberdorfer P, Akarathum N, Wannarit P, Sirisanthana T, Sirisanthana V. Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children. Pediatr Infect Dis J 2006; 25: 53-8. doi:10.1097/01. inf.0000195618.55453.9a PMID:16395104
34. Report of the WHO Technical Reference Group. Paediatric HIV/ART Care Guideline Group meeting: revised treatment recommendations for infants. Geneva: World Health Organization; 2008.
35. Sherman GG, Stevens G, Jones SA, Horsfield P, Stevens WS. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J Acquir Immune Defic Syndr 2005; 38: 615-7. doi:10.1097/01. qai.0000143604.71857.5d PMID:15793374
36. Creek T, Tanuri A, Smith M, Seipone K, Smit M, Legwaila K et al. Early diagnosis of human immunodeficiency virus in infants using polymerase chain reaction on dried blood spots in Botswana's national program for prevention of mother-to-child transmission. Pediatr Infect Dis J 2008; 27: 22-6. doi:10.1097/INF.0b013e3181469050 PMID:18162933
37. Cross Continents Collaboration for Kids (3Cs4kids) Analysis and Writing Committee. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. AIDS 2008; 22: 97-105. doi:10.1097/01.aids.0000302262.51286.a5 PMID:18090397
38. Anglaret X, Toure S, Gourvellec G, Tchehy A, Zio L, Zaho M et al. Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa. J Acquir Immune Defic Syndr 2004; 35: 320-3. doi:10.1097/00126334-200403010-00015 PMID:15076249
39. Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, Schouten EJ et al. True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ 2007; 85: 550-4. doi:10.2471/ BLT.06.037739 PMID:17768504
40. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D et al.; ART-LINC, IeDEA. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 2008; 86: 559-67. doi:10.2471/BLT.07.044248 PMID:18670668
41. Brinkhof MW, Pujades-Rodriguez M, Egger M, Emery S. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE 2009; 4: e5790. doi:10.1371/journal.pone.0005790 PMID:19495419
42. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008; 22: 1897-908. doi:10.1097/QAD.0b013e32830007cd PMID:18784453
43. Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grosskurth H et al. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 2009; 9: 290. doi:10.1186/1471-2458-9-290 PMID:19671185
44. Mofenson L. Challenges in pediatric and adolescent HIV care (abstract 65). In: Fifteenth Conference on Retroviruses and Opportunistic Infections, Boston, 3-6 February 2008.
45. van Griensven J, De Naeyer L, Uwera J, Asiimwe A, Gazille C, Reid T. Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/nurse-based care. BMC Pediatr 2008; 8: 39. doi:10.1186/1471- 2431-8-39 PMID:18831747